Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs
Clarissa A. Whitehead(The Royal Melbourne Hospital), Stanley S. Stylli(The Royal Melbourne Hospital)
Cited by 26
Related Papers
Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide
|Journal of neurosurgery|2017|23
Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs
|Cancers|2020|15
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
|Molecular and Cellular Biochemistry|2022|7